Home Contact Us Poly-Med, Inc. Banner
Poly-Med, Inc. Logo Poly-Med, Inc. Banner Poly-Med, Inc. Banner

Patents
2010/20092008/20072006/20052004/20032002/20012000/1999
1998/19971996/19951994
U.S. Patents Issued to Poly-Med, Inc.:
Segmented Copolyesters as Compliant Absorbable Coatings and Sealants for Vascular Devices  7,348,364  (2008)
Absorbable sealants or coatings for biomedical devices which are formulated from a segmented copolyester having a molecular weight of more than... read more-->

Conjugated Drug-Polymer Coated Stent  7,264,822  (2007)
One aspect of the invention is a system for treating vascular conditions, including a catheter, a stent coupled to the catheter, and a polymeric coating on the stent comprising at least one conjugated drug. Each conjugated drug includes a control agent and a bioactive agent... read more-->

Polyester/Cyanoacrylate Tissue Adhesive Compositions  7,351,426  (2008)
This invention addresses absorbable cyanoacrylate-based tissue adhesive compositions based primarily on an alkoxy cyanoacrylate combined with one or more alkyl cyanoacrylate(s), a stabilizer... read more-->

Conformable, Absorbable, Solid Composite Preforms and Their Use for Bone Tissue Engineering  7,244,445  (2007)
The present invention is directed to an absorbable, conformable composite perform for use in making a solid bone filler which is an absorbable mixture of oppositely charged, solid microparticulate polyelectrolytes encased in a sealed, flexible, absorbable copolyester fabric construct and is capable of undergoing solidi... read more-->

Composite Vascular Constructs with Selectively Controlled Properties  7,371,256  (2008)
This invention deals with a composite vascular construct, which is formed of a first, blood contacting component and a second, tissue contacting component. Preferably, the present vascular constructs are in the form of a... read more-->

High Strength Fibers of l-Lactide Copolymers, Ɛ-Caprolactone, and Trimethylene Carbonate and Absorbable Medical Constructs Thereof  7,192,437  (2007)
The present invention is directed to crystalline copolymers of l-lactide and a minor portion of a cyclic monomer, preferably Ɛ-carprolactone or trimethylene carbonate or both. The present copolymers have a melting temperature of at least 150ºC and a crystallinity of at least 20%. Preferred are high molecular weight c... read more-->

Surface Electroconductive Biostable Polymeric Articles  7,381,664  (2008)
Organic inherently conductive polymers, such as those based on polyaniline, polypyrrole and polythiophene, are formed in situ onto polymeric surfaces that are chemically activated to bond, ionically, the conductive polymers to the substrates... read more-->

Micromantled Drug-eluting Stent  7,416,559  (2008)
Pharmacologically active, easy-to-deploy, biomechanically compatible, inflatable, endovascular, drug-eluting stents are formed of a primary expandable polymeric or metallic construct, intimately mantled with a biomechanically compatible, polymeric microporous, microfibrous, compliant, stretchable fabric formed... read more-->

Crystalline High-compliance Glycolide Copolymers and Applications Thereof  7,435,789  (2008)
The present invention is directed toward an absorbable crystalline segmented copolymer comprising a polyalkylene succinate segment end-grafted in a single-step with a mixture of monomers comprising caprolactone... read more-->

Inorganic-Organic Melt-Extruded Hybrid Filaments and Medical Applications Thereof  7,465,489  (2008)
This invention deals with a family of inorganic-organic hybrid, melt-extruded filaments having variable cross-sectional geometry with a cross-sectional area ranging between 100μ2 and 4 mm2, wherein the inorganic component... read more-->

High Strength Fibers of l-Lactide Copolymers, ε-Caprolactone, and Trimethylene Carbonate and Absorbable Medical Constructs Thereof  European Patent EP 1 260 533  (2008)
The present invention is directed to crystalline copolymers of l-lactide and a minor portion of a cyclic monomer, preferably .epsilon.-caprolactone or trimethylene carbonate or both. The present copolymers have a melting temperature of at least 150.degree. C. and a crystallinity of at least 25%. Preferred are high mole read more-->